These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 37043085)
1. RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy. Xu Z; Huang J; Zhang T; Xu W; Liao X; Wang Y; Wang G J Mater Sci Mater Med; 2023 Apr; 34(4):18. PubMed ID: 37043085 [TBL] [Abstract][Full Text] [Related]
2. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200 [TBL] [Abstract][Full Text] [Related]
3. Preparation of Peptide and Recombinant Tissue Plasminogen Activator Conjugated Poly(Lactic-Co-Glycolic Acid) (PLGA) Magnetic Nanoparticles for Dual Targeted Thrombolytic Therapy. Chen HA; Ma YH; Hsu TY; Chen JP Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32294917 [TBL] [Abstract][Full Text] [Related]
4. Biomimetic nanoparticle loading obatoclax mesylate for the treatment of non-small-cell lung cancer (NSCLC) through suppressing Bcl-2 signaling. Chen S; Ren Y; Duan P Biomed Pharmacother; 2020 Sep; 129():110371. PubMed ID: 32563984 [TBL] [Abstract][Full Text] [Related]
5. A erythrocyte-platelet hybrid membrane coated biomimetic nanosystem based on ginsenosides and PFH combined with ultrasound for targeted delivery in thrombus therapy. Yang MY; Tu YF; Feng KK; Yin MD; Fang YF; Le JQ; Luo BY; Tan XR; Shao JW Colloids Surf B Biointerfaces; 2023 Sep; 229():113468. PubMed ID: 37515961 [TBL] [Abstract][Full Text] [Related]
6. Platelet Membrane Cloaked Nanotubes to Accelerate Thrombolysis by Thrombus Clot-Targeting and Penetration. Liu B; Victorelli F; Yuan Y; Shen Y; Hong H; Hou G; Liang S; Li Z; Li X; Yin X; Ren F; Li Y Small; 2023 Jan; 19(4):e2205260. PubMed ID: 36424174 [TBL] [Abstract][Full Text] [Related]
7. Dual drive mode polydopamine nanomotors for continuous treatment of an inferior vena cava thrombus. Fang D; Li T; Wu Z; Wang Q; Wan M; Zhou M; Mao C J Mater Chem B; 2021 Oct; 9(41):8659-8666. PubMed ID: 34608926 [TBL] [Abstract][Full Text] [Related]
8. Cyclic RGD functionalized liposomes encapsulating urokinase for thrombolysis. Zhang N; Li C; Zhou D; Ding C; Jin Y; Tian Q; Meng X; Pu K; Zhu Y Acta Biomater; 2018 Apr; 70():227-236. PubMed ID: 29412186 [TBL] [Abstract][Full Text] [Related]
9. Drug delivery under cover of erythrocytes extends drug half-life: A thrombolytic targeting therapy utilizing microenvironment-responsive artificial polysaccharide microvesicles. Shan L; Wang J; Tu H; Zhang W; Li H; Slezak P; Lu F; Lee D; Hu E; Geng Z; Lan G; Xie R Carbohydr Polym; 2024 Nov; 343():122505. PubMed ID: 39174110 [TBL] [Abstract][Full Text] [Related]
10. Construction and evaluation of Fe₃O₄-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis. Zhou J; Guo D; Zhang Y; Wu W; Ran H; Wang Z ACS Appl Mater Interfaces; 2014 Apr; 6(8):5566-76. PubMed ID: 24693875 [TBL] [Abstract][Full Text] [Related]
11. Novel biomimetic dual-mode nanodroplets as ultrasound contrast agents with potential ability of precise detection and photothermal ablation of tumors. Liang Y; Yang H; Li Q; Zhao P; Li H; Zhang Y; Cai W; Ma X; Duan Y Cancer Chemother Pharmacol; 2020 Sep; 86(3):405-418. PubMed ID: 32797251 [TBL] [Abstract][Full Text] [Related]
12. Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery. Zhao Y; Lin D; Wu F; Guo L; He G; Ouyang L; Song X; Huang W; Li X Int J Mol Sci; 2014 Sep; 15(10):17565-76. PubMed ID: 25268623 [TBL] [Abstract][Full Text] [Related]
13. Erythrocyte Membrane Cloaked Curcumin-Loaded Nanoparticles for Enhanced Chemotherapy. Xie X; Wang H; Williams GR; Yang Y; Zheng Y; Wu J; Zhu LM Pharmaceutics; 2019 Aug; 11(9):. PubMed ID: 31450749 [TBL] [Abstract][Full Text] [Related]
14. Thrombolysis based on magnetically-controlled surface-functionalized Fe Chang M; Lin YH; Gabayno JL; Li Q; Liu X Bioengineered; 2017 Jan; 8(1):29-35. PubMed ID: 27689864 [TBL] [Abstract][Full Text] [Related]
15. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma. Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800 [TBL] [Abstract][Full Text] [Related]
16. Thrombus-specific theranostic nanocomposite for codelivery of thrombolytic drug, algae-derived anticoagulant and NIR fluorescent contrast agent. Chang LH; Chuang EY; Cheng TM; Lin C; Shih CM; Wu AT; Jheng PR; Lu HY; Shih CC; Mi FL Acta Biomater; 2021 Oct; 134():686-701. PubMed ID: 34358695 [TBL] [Abstract][Full Text] [Related]
17. Biomimetic Antidote Nanoparticles: a Novel Strategy for Chronic Heavy Metal Poisoning. Wang H; Yao Q; Zhu W; Yang Y; Gao C; Han C; Chu X AAPS PharmSciTech; 2022 Nov; 24(1):12. PubMed ID: 36451071 [TBL] [Abstract][Full Text] [Related]
18. Preparation and Properties of Thrombus-Targeted Urokinase/Multi-Walled Carbon Nanotubes (MWCNTs)-Chitosan (CS)-RGD Drug Delivery System. Zhang R; Luo S; Hao LK; Jiang YY; Gao Y; Zhang NN; Zhang XC; Song YM J Biomed Nanotechnol; 2021 Sep; 17(9):1711-1725. PubMed ID: 34688316 [TBL] [Abstract][Full Text] [Related]
19. Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment. Zhang Z; Qian H; Yang M; Li R; Hu J; Li L; Yu L; Liu B; Qian X Int J Nanomedicine; 2017; 12():1593-1605. PubMed ID: 28280328 [TBL] [Abstract][Full Text] [Related]
20. Dual-mode nanoprobe strategy integrating ultrasound and near-infrared light for targeted and synergistic arterial thrombolysis. Wang Z; Jiang N; Jiang Z; Wang H; Guo Y; Zhong F; Gui B; Chen Y; Deng Q; Zhou Q; Hu B J Nanobiotechnology; 2024 Jun; 22(1):311. PubMed ID: 38831332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]